Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.
Front Immunol. 2023 Jul 31;14:1220558. doi: 10.3389/fimmu.2023.1220558. eCollection 2023.
Front Immunol. 2023.
PMID: 37600821
Free PMC article.
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab.
Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, Altmeyer S, Bittenbring JT, Augsberger C, Ilieva-Babinsky K, Haskamp S, Beier F, Lischer C, Vera J, Lührmann A, Bertz S, Völkl S, Jacobs B, Steidl S, Mackensen A, Bruns H.
Biedermann A, et al. Among authors: mangelberger eberl d.
Haematologica. 2024 Dec 1;109(12):3928-3940. doi: 10.3324/haematol.2023.284795.
Haematologica. 2024.
PMID: 38934068
Free PMC article.
Item in Clipboard
Enhanced Prenatal and Postnatal Development Study in Marmoset Monkeys Following Administration of Felzartamab.
Mangelberger-Eberl D, Cosenza ME, Härtle S, Luetjens CM, Welsh BT, Steidl S, Flesher DL, Chinn LW.
Mangelberger-Eberl D, et al.
Int J Toxicol. 2024 Dec;43(6):561-578. doi: 10.1177/10915818241289526.
Int J Toxicol. 2024.
PMID: 39526914
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.